
Matthew Gline
4 stock trades in the last 12 months, shares they bought or sold themselves (not grants or options).
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
The 3 newest of 4 trades
| Stock | Trade | Amount | Traded |
|---|---|---|---|
| Sell | $8.4M | Apr 16SEC filing | |
| Sell | $5M | Dec 15, 2025SEC filing | |
| Sell | $12.3M | Dec 15, 2025SEC filing |
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Matthew Gline's companies
| Stock | Trades | Quality Score |
|---|---|---|
| 4 |
Alerts for Matthew Gline
Use this page
How to cite
Breakaway, Matthew Gline: CEO at Roivant Sciences (ROIV), Nov 12, 2026, getbreakaway.com/insiders/matthew-gline
Journalists: email support@getbreakaway.com for the data behind this page.